COVID-19 pandemic distress among a sample of Italian psycho-oncologists: risk of isolation and loneliness.


Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 17 2 2021
medline: 16 2 2022
entrez: 16 2 2021
Statut: ppublish

Résumé

To measure the prevalence and characteristics of distress and hope for the future among psycho-oncologists, who faced the coronavirus disease 2019 (COVID-19) emergency along with other healthcare workers. A web-based study was conducted among members of the Italian Society of Psycho-Oncology between May 29 and June 5, 2020. A total of 237 members, aged 28-72 years, completed the COVID-19 Peritraumatic Distress Index (CPDI), Impact of Event Scale-Revised (IES-R), and HOPE questionnaires; 86.92% were female, 58.65% worked in hospitals, 21.10% were exposed to COVID-19, 11.39% experienced peritraumatic distress, and 3.38% had posttraumatic stress disorder symptoms. Peritraumatic distress was associated with living alone (adjusted odds ratio [AOR] 3.05; 95% confidence interval [CI] 1.41-8.13), using sleep remedies (AOR 3.79; 95% CI 1.41-10.21), and the perception of being avoided by family or friends because of work (AOR 2.69; 95% CI 1.02-7.11); high HOPE-Agency scores were associated with the absence of peritraumatic stress (AOR 0.40; 95% CI 0.16-0.96) after adjustment for age and sex. Psycho-oncologists showed greater resilience than other healthcare workers as they are trained to help others, but also to review their own values and behavior in light of stressful events. Of interest is the association between peritraumatic distress and social isolation, real or perceived. Healthcare institutions should pay attention to the mental well-being of their employees by promoting distress screening using simple tools such as the CPDI and implementing support interventions. Psycho-oncology associations should introduce policies aimed at developing a sense of social connectedness by providing an interactive system of orientation and scientific reference.

Identifiants

pubmed: 33588706
doi: 10.1177/0300891621992129
pmc: PMC7890420
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-85

Références

Med Sci Monit. 2020 Mar 05;26:e923549
pubmed: 32132521
Lancet Oncol. 2011 Aug;12(8):753-62
pubmed: 21741309
JAMA. 2020 Jun 9;323(22):2235-2236
pubmed: 32432665
J Appl Psychol. 2016 Jan;101(1):35-49
pubmed: 26098165
JAMA Oncol. 2020 Nov 1;6(11):1700-1701
pubmed: 32701132
Riv Psichiatr. 2020 May-Jun;55(3):145-151
pubmed: 32489191
Int J Environ Res Public Health. 2020 Jul 02;17(13):
pubmed: 32630821
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Front Psychiatry. 2020 Aug 07;11:790
pubmed: 32848952
Oncol Lett. 2020 Jul;20(1):441-447
pubmed: 32565968
Psychiatry Res. 2020 Aug;290:113129
pubmed: 32485487
Psychoneuroendocrinology. 2013 Sep;38(9):1883-94
pubmed: 23856187
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
J Clin Psychol. 2018 Sep;74(9):1431-1456
pubmed: 29574725
BMJ. 2020 May 5;369:m1642
pubmed: 32371466
JAMA Intern Med. 2020 Aug 1;180(8):1047-1048
pubmed: 32597924
Psychiatry Res. 2020 Sep;291:113190
pubmed: 32563745
JAMA Intern Med. 2020 Jul 1;180(7):1020-1022
pubmed: 32259192
Front Psychol. 2018 Oct 16;9:1897
pubmed: 30386275
J Pers Soc Psychol. 1991 Apr;60(4):570-85
pubmed: 2037968
Annu Rev Psychol. 2015 Jan 3;66:733-67
pubmed: 25148851
Eur Neuropsychopharmacol. 2020 Jun;35:12-16
pubmed: 32446705
JAMA. 2020 Jul 7;324(1):93-94
pubmed: 32492088
Brain Behav Immun. 2020 Aug;88:559-565
pubmed: 32330593
Perspect Psychol Sci. 2015 Mar;10(2):227-37
pubmed: 25910392
JAMA. 2020 Jul 28;324(4):345-346
pubmed: 32602892

Auteurs

Anna Costantini (A)

Psycho-Oncology Departmental Unit, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Eva Mazzotti (E)

Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Samantha Serpentini (S)

Psycho-Oncology Unit, Veneto Institute of Oncology IOV-IRCCS Comprehensive Cancer Center, Padua, Italy.

Angela Piattelli (A)

UOC Oncologia-Dipartimento Oncoematologico, Azienda Ospedaliera Cosenza, Cosenza, Italy.

Dorella Scarponi (D)

Paediatric Unit, Sant'Orsola Hospital, Bologna University, Bologna, Italy.

Gabriella De Benedetta (G)

Hematology Department, National Cancer Institute, Foundation Pascale, Naples, Italy.

Marco Bellani (M)

Psycho-oncology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH